BFRINasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BFRIW
Biofrontera Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.81−0.02 (-1.94%)
Close on Oct 19, 2026
- Market cap
- $10.41M
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
$41.71MFY2025, +17.2% a year since FY2020